![Michael Dybbs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Dybbs
Directeur/Membre du Conseil chez
SPYGLASS PHARMA, INC.
Fortune : - $ au 30/06/2026
Profil
Dr. Michael P.
Dybbs is an Independent Director at SpyGlass Pharma, Inc., an Independent Director at Kalaris Therapeutics, Inc., an Independent Director at Nkarta, Inc., an Independent Director at Sutro Biopharma, Inc., a Partner at Samsara BioCapital LLC and a Director & Investor at Fluent BioSciences, Inc. He is on the Board of Directors at SpyGlass Pharma, Inc., Kalaris Therapeutics, Inc., Nkarta, Inc., Sutro Biopharma, Inc., 565 SPV I LP, IONpath, Inc., Kalaris TX, Inc., Levo Therapeutics, Inc., Samsara BioCapital LP and Fluent BioSciences, Inc. Dr. Dybbs was previously employed as an Independent Director by Dimension Therapeutics, Inc., an Independent Director by Versartis, Inc., a Partner by New Leaf Venture Partners LLC, and a Principal by The Boston Consulting Group, Inc. He also served on the board at Principia Biopharma, Inc., Advanced Cell Diagnostics, Inc. and Rayzebio, Inc. He received his undergraduate degree from Harvard University and a doctorate degree from the University of California, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 03/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| 05/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 | |
NKARTA, INC. -.--% | 10/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| 05/02/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Michael Dybbs
| Sociétés | Poste | Début |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Directeur/Membre du Conseil | 25/07/2018 |
| NKARTA, INC. | Directeur/Membre du Conseil | 01/08/2019 |
| SPYGLASS PHARMA, INC. | Directeur/Membre du Conseil | 01/11/2025 |
Theia Therapeutics, Inc.
 Theia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes treatments for prevalent retinal diseases | Fondateur | - |
Fluent BioSciences, Inc.
 Fluent BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops differentiated single-cell technology products | Directeur/Membre du Conseil | - |
Samsara BioCapital LP
 Samsara BioCapital LP Investment ManagersFinance Acts as Venture Capital Fund | Directeur/Membre du Conseil | - |
565 SPV I LP
 565 SPV I LP Investment ManagersFinance Functions as venture capital fund | Directeur/Membre du Conseil | - |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Private Equity Investor | 01/01/2017 |
IONpath, Inc.
 IONpath, Inc. Medical/Nursing ServicesHealth Services Transforms pathology with multiplexed ion beam imaging | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Dybbs
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░ ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Michael Dybbs
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
86
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Finance |
Advanced Cell Diagnostics, Inc.
 Advanced Cell Diagnostics, Inc. BiotechnologyHealth Technology Develops cell and tissue based diagnostic tests | Health Technology |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for rare diseases | Health Technology |
IONpath, Inc.
IONpath, Inc. Medical/Nursing ServicesHealth Services Transforms pathology with multiplexed ion beam imaging | Health Services |
Samsara BioCapital LP
Samsara BioCapital LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Finance |
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research into therapeutics | Health Technology |
Nkarta, Inc.
 Nkarta, Inc. BiotechnologyHealth Technology Discovers, develops and delivers NK cell therapies for cancer treatment | Health Technology |
565 SPV I LP
565 SPV I LP Investment ManagersFinance Functions as venture capital fund | Finance |
Fluent BioSciences, Inc.
Fluent BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops differentiated single-cell technology products | Commercial Services |
Rayzebio, Inc.
 Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
Theia Therapeutics, Inc.
Theia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes treatments for prevalent retinal diseases | Health Technology |
SpyGlass Pharma Inc
 SpyGlass Pharma Inc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops IOL-mounted drug delivery platform for glaucoma patients | Health Technology |
